Effect of combined contraceptive pill on immune cell of ovarian endometriotic tissue

Department of Obstetrics and Gynecology, Faculty of Medicine, Ramathibodi Hospital0 个研究点目标入组 44 人开始时间: 2017年4月25日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•1.Healthy female subjects age 18-45 years old.
•2.Subjects who were diagnosed with endometriotic cyst with size equal or more than 3 centimeters.
•3.Subjects who have no previous records of taking any kinds of hormones during 3 months prior to the study and those who were not recieved depot-medroxyprogesterone acetate (DMPA) or GnRHa within 9 months prior to the study.
•4.Subjects who have no limitations in taking either ethinyl estradiol with Desogestrel.
•5.Subjects who are willing to participate in the study program.

•1.Subjects with underlying disease that contraindicate to receive ethinyl estradiol and desogestrel such as Cirrhosis, Chronic kidney disease, Coagulopathy, Heart disease and Pulmonary disease.
•2.Subjects who have contraindication to taking either ethinyl estradiol and desogestrel
•3.Subjects who are intolerable to irregularity of menstruation cycle.
•4.Subjects who rejected or withdrew from the study.

发起方

Department of Obstetrics and Gynecology, Faculty of Medicine, Ramathibodi Hospital